European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies
NCT05043506
·
clinicaltrials.gov ↗
COMPLETED
Status
1939
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Palbociclib + aromatase inhibitor
DRUG:
Aromatase inhibitor
Sponsor
Pfizer